aTyr Pharma | LIFE - Выручка от реализации





Продажи Изменить Дата
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
Ardelyx USD 125.21M 14.89M 2025-12
aTyr Pharma USD 110.08M 109.89M 2025-12
Biogen USD 2.28B 250M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Cipla INR 75.18B 710M 2025-12
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 67.33M 65.44M 2025-12
CSL USD 8.33B 4.79B 2025-12
Curis USD 1.14M 1.41M 2025-12
Galapagos EUR 900.82M 835.52M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Grifols EUR 2.34B 33.3M 2026-03
Novartis USD 13.86B 50M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
United Therapeutics USD 790.2M 9.3M 2025-12
Xoma USD 25K 5M 2024-09